FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 41 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,070 | -43.6% | 4,004 | -33.7% | 0.00% | – |
| Q2 2023 | $53,307 | -73.9% | 6,037 | -81.6% | 0.00% | – |
| Q1 2021 | $204,000 | -19.4% | 32,818 | -3.3% | 0.00% | – |
| Q4 2020 | $253,000 | +28.4% | 33,934 | +4.2% | 0.00% | – |
| Q3 2020 | $197,000 | -27.6% | 32,568 | 0.0% | 0.00% | – |
| Q2 2020 | $272,000 | +198.9% | 32,568 | +74.4% | 0.00% | – |
| Q1 2019 | $91,000 | -23.5% | 18,673 | 0.0% | 0.00% | – |
| Q4 2018 | $119,000 | -16.2% | 18,673 | +7.7% | 0.00% | – |
| Q3 2018 | $142,000 | -21.5% | 17,340 | 0.0% | 0.00% | – |
| Q2 2018 | $181,000 | – | 17,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 960,000 | $8,016,000 | 7.40% |
| Sonic Fund II, L.P. | 1,634,689 | $13,650,000 | 6.79% |
| Southpoint Capital Advisors LP | 4,077,214 | $34,045,000 | 0.83% |
| 683 Capital Management, LLC | 1,110,000 | $9,269,000 | 0.74% |
| Opaleye Management Inc. | 171,000 | $1,428,000 | 0.29% |
| Avoro Capital Advisors LLC | 1,670,000 | $13,945,000 | 0.28% |
| Eventide Asset Management | 1,120,000 | $9,352,000 | 0.20% |
| CADENCE CAPITAL MANAGEMENT LLC | 153,556 | $1,282,000 | 0.19% |
| Hartford Financial Management Inc. | 49,548 | $414,000 | 0.13% |
| Granahan Investment Management | 245,377 | $2,049,000 | 0.07% |